Skip to main content

Table 1 Number of samples contributing to each class and omic type for each dataset

From: Inferring pathway dysregulation in cancers from multiple types of omic data

Analysis Class 1 Class 2 Somatic mutation RNA-Seq CNV Microarray
p53 mutation status 17 33 - - - 50
Wild-type p53-mutated
Gender 15 17 - - - 32
Male Female
RAS mutation status (TCGA LUAD) 66 161 - 169 - -
Wild-type RAS-mutated
HER2 analysis (TCGA breast) 58 489 506 508 308 519
HER2 + Other breast
USC analysis (TCGA endometrial) 53 USC 307 UEC 244 323 353 -
  1. LUAD, lung adenocarcinoma; UCS, uterine serous carcinoma; UES, uterine endometrioid carcinoma